Event-related potentials improve the efficiency of cerebrospinal fluid biomarkers for differential diagnosis of alzheimer’s disease

Keyphrases

• Differential Diagnosis 100%
• Event-related Potentials 100%
• Alzheimer's Disease Diagnosis 100%
• Cerebrospinal Fluid Biomarkers 100%
• Alzheimer's Disease 85%
• Mild Cognitive Impairment 85%
• Alzheimer's Disease Patient 42%
• Reaction Time 42%
• P300 Latency 42%
• Protein Biomarkers 42%
• Tau Protein 42%
• Strong Correlation 28%
• P-tau181 28%
• Total tau 28%
• P300 28%
• Threonine 28%
• Cerebrospinal Fluid Protein 28%
• Visinin-like protein-1 28%
• P-tau231 28%
• Causes of Dementia 28%
• N200 28%
• High Risk 14%
• Control Subjects 14%
• Disease Diagnosis 14%
• Healthy Controls 14%
• Clinical Practice 14%
• Diagnostic Potential 14%
• Electroencephalography 14%
• Clinical Symptoms 14%
• Predictive Models 14%
• Neuropsychological Tests 14%
• Cerebrospinal Fluid 14%
• Latency Time 14%
• Early Diagnosis 14%
• Pathological Process 14%
• Amyloid-β Peptide 14%
• Acetylcholinesterase Inhibitors (AChEI) 14%
• Combined Events 14%
• Diagnostic Efficiency 14%
• Disease Likelihood 14%
• Potential Fluid 14%

Biochemistry, Genetics and Molecular Biology

• Liquid 100%
• Event-Related Potential 100%
• Tau Protein 42%
• Protein Cerebrospinal Fluid Level 42%
• Phosphorylated Protein 42%
• Tau 28%
• Synapsin I 28%
• Threonine 28%
• Solution and Solubility 14%
• Acetylcholinesterase 14%
• Amyloid Protein 14%
• Serine 14%

Neuroscience

• Alzheimer's Disease 100%
• Event-Related Potential 100%
• Differential Diagnosis 100%
• Mild Cognitive Impairment 46%
• Tau Protein 23%
• Threonine 15%
• Synapsin I 15%
• Visinin 15%
• Electroencephalography 7%
• Serine 7%
• Acetylcholinesterase Inhibitor 7%
• Amyloid Protein 7%